We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$48B
AUM Growth
-$1.59B
(-3.2%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-3.05%
Top 10 Holdings %
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$60.6M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$50.8M |
| 3 |
Mastercard
MA
|
+$43.1M |
| 4 |
Analog Devices
ADI
|
+$40.3M |
| 5 |
Broadcom
AVGO
|
+$40.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$92.3M |
| 2 |
NVIDIA
NVDA
|
+$92.1M |
| 3 |
Eli Lilly
LLY
|
+$80.8M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$74.2M |
| 5 |
Microsoft
MSFT
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.14% |
| 2 | Financials | 15.08% |
| 3 | Healthcare | 14.69% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Twist Bioscience
TWST
$5.51B
| $7.68M | 0.02% |
71,770
+13,791
| +24% | +$1.58M |
|
502
Principal Financial Group
PFG
$24.6B
| $7.65M | 0.02% |
118,842
-37,489
| -24% | -$2.41M |
|
503
Synopsys
SNPS
$73.5B
| $7.65M | 0.02% |
25,563
+2,513
| +11% | +$763K |
|
504
NNN REIT
NNN
$9.37B
| $7.63M | 0.02% |
176,774
-5,600
| -3% | -$263K |
|
505
Commerce Bancshares
CBSH
$8.64B
| $7.61M | 0.02% |
139,330
| – | – |
|
506
West Pharmaceutical
WST
$23.7B
| $7.6M | 0.02% |
17,894
-2,213
| -11% | -$933K |
|
507
Wyndham Hotels & Resorts
WH
$5.62B
| $7.55M | 0.02% |
97,800
-785
| -0.8% | -$56.3K |
|
508
Edwards Lifesciences
EW
$48.2B
| $7.54M | 0.02% |
66,609
+114
| +0.2% | +$13K |
|
509
Middleby
MIDD
$6.11B
| $7.53M | 0.02% |
44,160
+2,160
| +5% | +$390K |
|
510
Affiliated Managers Group
AMG
$9.78B
| $7.52M | 0.02% |
49,775
+2,830
| +6% | +$463K |
|
|
CONE
511
DELISTED
CyrusOne Inc Common Stock
CONE
| $7.47M | 0.02% |
96,540
+300
| +0.3% | +$22.6K |
|
512
Annaly Capital Management
NLY
$17.4B
| $7.4M | 0.02% |
219,713
-136,000
| -38% | -$4.68M |
|
513
Darden Restaurants
DRI
$23.7B
| $7.27M | 0.02% |
47,988
+21,643
| +82% | +$3.18M |
|
514
Cullen/Frost Bankers
CFR
$10.5B
| $7.25M | 0.02% |
61,094
+10,525
| +21% | +$1.17M |
|
515
Labcorp
LH
$25.8B
| $7.24M | 0.02% |
29,925
-3,071
| -9% | -$774K |
|
516
RenaissanceRe
RNR
$13.9B
| $7.21M | 0.02% |
51,722
+10,705
| +26% | +$1.62M |
|
517
Devon Energy
DVN
$49.2B
| $7.18M | 0.02% |
202,206
+132,333
| +189% | +$3.75M |
|
518
SS&C Technologies
SSNC
$18.8B
| $7.11M | 0.01% |
102,450
+8,895
| +10% | +$659K |
|
519
Cytokinetics
CYTK
$10.8B
| $7.1M | 0.01% |
198,555
-4,000
| -2% | -$118K |
|
520
BJs Wholesale Club
BJ
$12.4B
| $7.01M | 0.01% |
127,600
+10,700
| +9% | +$571K |
|
521
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $6.87M | 0.01% |
72,971
+16,660
| +30% | +$1.53M |
|
522
Sunrun
RUN
$2.3B
| $6.85M | 0.01% |
155,600
+13,500
| +10% | +$644K |
|
523
Macy's
M
$6.62B
| $6.82M | 0.01% |
301,600
+9,100
| +3% | +$182K |
|
524
WEX
WEX
$6.23B
| $6.81M | 0.01% |
38,653
-180
| -0.5% | -$32.8K |
|
|
JHG
525
DELISTED
Janus Henderson
JHG
| $6.8M | 0.01% |
164,445
+30,640
| +23% | +$1.27M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.
- Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
- Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
- Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
- Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
- Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
- Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
- Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.
Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.